391 related articles for article (PubMed ID: 11889151)
1. Adrenal incidentaloma: a new cause of the metabolic syndrome?
Terzolo M; Pia A; Alì A; Osella G; Reimondo G; Bovio S; Daffara F; Procopio M; Paccotti P; Borretta G; Angeli A
J Clin Endocrinol Metab; 2002 Mar; 87(3):998-1003. PubMed ID: 11889151
[TBL] [Abstract][Full Text] [Related]
2. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
3. Nondiabetic patients with either subclinical Cushing's or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: clinical implications.
Ivović M; Marina LV; Vujović S; Tančić-Gajić M; Stojanović M; Radonjić NV; Gajić M; Soldatović I; Micić D
Metabolism; 2013 Jun; 62(6):786-92. PubMed ID: 23332445
[TBL] [Abstract][Full Text] [Related]
4. Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
[TBL] [Abstract][Full Text] [Related]
5. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.
Tauchmanovà L; Rossi R; Biondi B; Pulcrano M; Nuzzo V; Palmieri EA; Fazio S; Lombardi G
J Clin Endocrinol Metab; 2002 Nov; 87(11):4872-8. PubMed ID: 12414841
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?
Peppa M; Boutati E; Koliaki C; Papaefstathiou N; Garoflos E; Economopoulos T; Hadjidakis D; Raptis SA
Metabolism; 2010 Oct; 59(10):1435-41. PubMed ID: 20153874
[TBL] [Abstract][Full Text] [Related]
7. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma.
Fernández-Real JM; Engel WR; Simó R; Salinas I; Webb SM
Clin Endocrinol (Oxf); 1998 Jul; 49(1):53-61. PubMed ID: 9797847
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone secretion in primary adrenal Cushing's syndrome is disorderly and inversely correlated with body mass index.
van Aken MO; Pereira AM; Frölich M; Romijn JA; Pijl H; Veldhuis JD; Roelfsema F
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E63-70. PubMed ID: 15328071
[TBL] [Abstract][Full Text] [Related]
12. The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis.
Osella G; Reimondo G; Peretti P; Alì A; Paccotti P; Angeli A; Terzolo M
J Clin Endocrinol Metab; 2001 Feb; 86(2):604-7. PubMed ID: 11158016
[TBL] [Abstract][Full Text] [Related]
13. The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection.
Midorikawa S; Sanada H; Hashimoto S; Suzuki T; Watanabe T
Clin Endocrinol (Oxf); 2001 Jun; 54(6):797-804. PubMed ID: 11422115
[TBL] [Abstract][Full Text] [Related]
14. Subclinical Cushing's syndrome in adrenal incidentalomas--possible metabolic consequences.
Bohdanowicz-Pawlak A; Szymczak J; Waszczuk E; Bolanowski M; Bednarek-Tupikowska G
Endokrynol Pol; 2013; 64(3):186-91. PubMed ID: 23873421
[TBL] [Abstract][Full Text] [Related]
15. Determinants of serum leptin levels in Cushing's syndrome.
Widjaja A; Schürmeyer TH; Von zur Mühlen A; Brabant G
J Clin Endocrinol Metab; 1998 Feb; 83(2):600-3. PubMed ID: 9467580
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features and outcomes of surgical versus conservative management in patients with subclinical Cushing's syndrome].
Liu MS; Zhang WJ; Zhu KY; Feng WH; Huang H; Zhu DL; Li P
Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(36):2834-2840. PubMed ID: 32988143
[No Abstract] [Full Text] [Related]
17. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma.
Terzolo M; Bovio S; Pia A; Conton PA; Reimondo G; Dall'Asta C; Bemporad D; Angeli A; Opocher G; Mannelli M; Ambrosi B; Mantero F
Eur J Endocrinol; 2005 Aug; 153(2):307-15. PubMed ID: 16061838
[TBL] [Abstract][Full Text] [Related]
18. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
19. [The influence of physical training on metabolic indices in men with myocardial infarction and impaired glucose tolerance].
Stochmal A; Jasiak-Tyrkalska B; Stochmal E; Huszno B; Kawecka-Jaszcz K
Przegl Lek; 2007; 64(6):410-5. PubMed ID: 18159849
[TBL] [Abstract][Full Text] [Related]
20. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
Diamanti-Kandarakis E; Spina G; Kouli C; Migdalis I
J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
